Chemical Structure (Image 01)
Nubeqa Tablet, Film Coated
Product Images NDC 50419-395
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nubeqa (NDC 50419-395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Plan Meier Curve Metastases Free Survival (Image 02)
This appears to be a table with data related to Metastasis Free Survival Probability for patients taking NUBEQA and Placebo. It includes the number of patients in each group, censorship information, and patients at risk over a period of months from randomization. There is no additional context or information available.*
Nubeqa 300 mg Label (Image 03)
The text contains a mix of readable text and non-readable characters, so it is not possible to generate a useful description.*
Image 04
This appears to be a graph showing Overall Survival Probability for NUBEQA vs Placebo as well as the number of patients at risk over time. The graph presents the data at different time intervals, starting from 24 months up to 60 months, and displays the percentage of overall survival probability for both NUBEQA (955) and Placebo (554) groups. Patients at risk are also presented on the graph. It's unclear what the numbers on top - 100, 90, 80, 60, 50, 30, 20, and 10 represent, but they might be showing the probability of the disease persisting at different stages.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
